Impact of transmitted COVID-19 on the main cardiovascular risk factors in people of different ages
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
https://orcid.org/0000-0002-2282-2975
Abstract
The aim – to clarify the impact of SARS-CoV-2 on the development of metabolic disorders in middle-aged and elderly people in the period from 1 to 3 months after suffering from the disease of COVID-19.
Materials and methods. All of included in our study people was divided anthropometric measurements, capillaroscopy, aggregometry, a standard glucose-tolerance test with determination of the index of insulin resistance and functional activity of β-cells of the pancreas, parameters of the lipid spectrum of blood serum were determined and risk indices of cardiovascular diseases and diabetes were assessed too.
Results and discussion. Ours results showed an increase in cardiovascular risk indicators (Castelli, Boizel, SCORE-2 indices) and type 2 diabetes after COVID-19 disease. A very high index of cardiovascular risk according to the SCORE-2 scale was determined in the older age group, especially in those who were illness with COVID-19. The glucose concentration and insulin after the COVID-19 disease in middle-aged persons is higher than in persons without a history of COVID-19, accompanied by an increase in the functional activity of β-cells, which indicates a significant stress on the islet apparatus of the pancreas, presumably compensatory. On the contrary, in the elderly, a reduced functional reserve of β-cells of the islet apparatus of the pancreas was found, which probably determines their high risk of type 2 diabetes in the next 10 years according to the FINDRISK scale. An increase in the aggregation ability of platelets and changes in the nature of blood flow at the level of the microcirculatory link of the circulatory system were noted in persons who contracted COVID-19.
Conclusions. Individuals with COVID-19 have higher cardiovascular risk score – Castelli, Boizel, SCORE-2, and type 2 diabetes. Middle-aged people already have prediabetic disorders, which are characterized not only by hyperglycemia, but also accompanied by hyperinsulinemia with insulin resistance against the background of increased functional activity of the islet apparatus of the pancreas. In the elderly, hyperglycemia is accompanied by a decrease in the functional activity of the islet apparatus of the pancreas with a decrease in insulin production and hyperglycemia. Probably, SARS-CoV-2 acts as a trigger for the manifestation of the disease, especially in the group of elderly people.
Article Details
Keywords:
References
Vasapollo IB, Valensise H, Pierangela T. SARS-CoV-2, endothelial dysfunction, and the renin-angiotensin system (RAS): A potentially dangerous triad for the development of pre-eclampsia. Reprod Med. 2021;2(2):95-106. https://doi.org/10.3390/reprodmed2020010
Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533-5. https://doi.org/10.1038/s41423-020-0402-2
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. https://doi.org/10.1016/j.ijid.2020.03.017
Saxena SK, Kumar S, Maurya VK, Sharma R, Dandu HR, Bhatt MLB. Current information on the 2019 novel coronavirus disease (COVID-19). Coronavirus Disease 2019 (COVID-19). 2020;1-8. https://doi.org/10.1007/978-981-15-4814-7_1
Geng YJ, Wei ZY, Qian HY, Huang J, Lodato R, Castriotta RJ. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47:107-228. https://doi.org/10.1016/j.carpath.2020.107228
Xin Z, Ke C, Jiawei Z, Peiyi H, Jie H, Zeguang H. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185-92. https://doi.org/10.1007/s11684-020-0754-0
Hao X, Liang Z, Jiaxin D, Jiakuan P, Hongxia D, Xin Z, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. https://doi.org/10.1038/s41368-020-0074-x
Rabi F, Al Zoubi M, Kasasbeh G, Salameh D, Al-Nasser A. SARS-CoV-2 and coronavirus disease 2019: What we know so far. Pathogens. 2020;9(3):231. https://doi.org/10.3390/pathogens9030231
Chee YJ, Ng SJ, Yeoh E. Diabetic ketoacidosis precipitated by COVID-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;164:108166. https://doi.org/10.1016/j.diabres.2020.108166
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
American Diabetes Association. Standards of medical care in diabetes – 2023. Diabetes Care. 2023;46(Suppl 1):S20-S21. https://doi.org/10.2337/dc23-Sint
McAuley KA, Williams SM, Mann JI. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460-4. https://doi.org/10.2337/diacare.24.3.460
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9. https://doi.org/10.1007/BF00280883
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502. https://doi.org/10.1093/clinchem/18.6.499
Duarte BG, Gínez IZ, Duarte RG, Rasgado ET, Vivanco GR, Fuentes RP. The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index as a reference criterion of risk for metabolic syndrome and low insulin sensitivity in apparently healthy subjects. Gac Med Mex. 2017;153(2):152-8. PMID: 28474700
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3209-13. https://doi.org/10.1093/eurheartj/ehab484
Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Dulbecco CA, Reaven GM. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals. Nutr Metab Cardiovasc Dis. 2017;27(4):366-73. https://doi.org/10.1016/j.numecd.2016.12.002
Chee YJ, Ng SJ, Yeoh E. Diabetic ketoacidosis precipitated by COVID-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;164:108-66. https://doi.org/10.1016/j.diabres.2020.108166
Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020;164:108214. https://doi.org/10.1016/j.diabres.2020.108214